Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease.
CONCLUSIONS: The present study indicated that long-term oral low-dose aspirin was safe for patients with both TBAD and coronary heart disease who underwent EVAR. For the patients who underwent both EVAR and PCI, DAPT also showed no increase in hemorrhage, endoleak, recurrent dissection, death, and myocardial infarction.
PMID: 28937039 [PubMed - in process]
Source: Chinese Medical Journal - Category: General Medicine Authors: He RX, Zhang L, Zhou TN, Yuan WJ, Liu YJ, Fu WX, Jing QM, Liu HW, Wang XZ Tags: Chin Med J (Engl) Source Type: research
More News: Academia | Angiography | Angioplasty | Aspirin | Bleeding | Cardiology | China Health | Clopidogrel | Coronary Angioplasty | Coronary Heart Disease | Diabetes | Diabetes Type 2 | Endocrinology | Endovascular Repair (EVAR) | Gastroschisis Repair | General Medicine | Heart | Heart Attack | Heart Disease | Hypertension | Percutaneous Coronary Intervention | Plavix | Study